Session sponsor
Sponsored education
Kate Wakelin (NET NP) will deliver an engaging and practical session on the development of nurse-led care models for the care of patients undertaking community delivered therapies (e.g. targeted therapies, oral chemotherapies, immunotherapies, and home-injectables), with a particular focus on preventing, assessing, and managing associated toxicities. Her presentation will equip nurses with evidence‑informed strategies to support patients throughout treatment and optimise quality of life.
Esther White, CNC Medical Oncology, will follow with a deep dive into nursing considerations specific to Zejula (niraparib). She will outline key monitoring requirements, common adverse effects, and best‑practice approaches to patient education and supportive care, ensuring nurses feel confident and well‑prepared when caring for patients receiving this therapy.